Tuesday, April 25, 2017 1:53:18 PM
You say the company will be cash flow positive, wouldn't that statement be a bit premature as well? Right?
The stock reflects what the general public feels about IPCI right now.
Can IPCI secure a Rexista deal to pave the way for advancing the pipeline? That may also generate enough funding to go into the next year or two at the very least.
I kept myself from buying a lot more shares just yet because I too felt the same way. Management can say what they want, whether or not they deliver is what really matters.
I am not looking just for break even. As I said, biotech needs to be constantly advancing their pipeline. They might be break even now, but we know competition will eventually drive profit lower as seen with Facolin. You see why people aren't willing to hold just yet? Simply because there is nothing that secures a big upside for the future.
As IPCI gets more approval, and increase revenue, it will make a lot more investors feel at ease buying and holding. A Rexista and PODRAS deal would really be the key to the future. But again, using your word, it's a bit premature wouldn't you say?
I am not saying IPCI will fail or anything, I'm just pointing out what general public feels about IPCI right now. On watch but won't commit just yet.
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
- L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - IPCI • PR Newswire (Canada) • 06/08/2023 05:30:00 PM
- Canadian Investment Regulatory Organization Trade Resumption - IPCI • PR Newswire (Canada) • 06/08/2023 05:28:00 PM
- Intellipharmaceutics Announces Fiscal Year 2022 and First Quarter 2023 Results • PR Newswire (Canada) • 06/06/2023 10:00:00 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM